[Evaluation of the long-term effects of the administration of gliquidone in subjects with diabetes type II].
Monda
M
M
Gatti
A
A
Dell'Aversano
R
R
Bonavita
M
M
Bocchino
C
C
Giacometti
F
F
Carleo
R
R
D000328:Adult; D000368:Aged; D001786:Blood Glucose / Q000378:metabolism; D002096:C-Peptide / Q000097:blood; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000188:drug therapy*; D005260:Female; D006442:Glycated Hemoglobin / Q000378:metabolism; D006801:Humans; D007328:Insulin / Q000097:blood; D008055:Lipids / Q000097:blood; D008297:Male; D008875:Middle Aged; D009584:Nitrogen / Q000097:blood; D013453:Sulfonylurea Compounds / Q000627:therapeutic use*
D001786:Blood Glucose; D002096:C-Peptide; D006442:Glycated Hemoglobin; D007328:Insulin; D008055:Lipids; D009584:Nitrogen; D013453:Sulfonylurea Compounds; C010969:gliquidone
Valutazione degli effetti a lungo termine della somministrazione di gliquidone in soggetti diabetici di tipo II.